|
rdfs:label
|
"Ixazomib"@de
"Ixazomib"@es
"Ixazomib"@vi
"iksatsomibi"@fi
"iksazomib"@nn
"iksazomib"@sl
"ixazomib"@en
"ixazomib"@fr
"ixazomibe"@pt
"إيكزازوميب"@ar
"ایکسازومیب"@fa
"ଇକ୍ସାଜୋମିବ"@or
"ఇక్సాజోమిబ్"@te
"イキサゾミブ"@ja
"伊沙佐米"@zh
|
|
skos:altLabel
|
"Ixazomib"@en
"ixazomib"@nn
"నిన్లారో"@te
|
|
schema:description
|
"Kompozé chimik"@gcr
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ఔషధం"@te
"രാസസംയുക്തം"@ml
"化合物"@yue
"化合物"@zh
"化合物"@zh-cn
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
|
|
schema:dateModified
|
"2026-11-04T16:42:07+00:00"^^xsd:dateTime
|
|
schema:version
|
2564763915
|
|
wikibase:identifiers
|
35
|
|
wikibase:sitelinks
|
12
|
|
wikibase:statements
|
65
|
|
p:P10245
|
wd:statement/Q20948663-3aaed9f4-4390-9e87-c58b-b34751691ee9
|
|
p:P10283
|
wd:statement/Q20948663-C1559D1F-ED59-4C89-BEB4-86EC93D5A663
|
|
p:P11089
|
wd:statement/Q20948663-B2E7D8A9-E15F-4940-BA3B-930FF40AA428
|
|
p:P11143
|
wd:statement/Q20948663-F56146A0-5275-47CA-9FB9-6D3699778544
|
|
p:P11198
|
wd:statement/Q20948663-4E5A705B-4A2F-473A-82DF-20A256F998BE
|
|
p:P11199
|
wd:statement/Q20948663-6EA09A33-7F12-4155-AF56-A521ECA26447
|
|
p:P129
|
wd:statement/Q20948663-063899F5-67B4-4F2A-BE97-936717C18EA0
|
|
wd:statement/Q20948663-0805CD16-3AF4-4555-8219-7020D2F5063A
|
|
wd:statement/Q20948663-14F05A00-4A8A-4C54-988A-E818C530E2C0
|
|
wd:statement/Q20948663-3EBEF758-B2F4-4937-AC4B-1D8EC81A419D
|
|
wd:statement/Q20948663-433FA83E-190F-419B-86C6-8EA3EC1ECA76
|
|
wd:statement/Q20948663-43D73ED7-0E4F-4F81-9825-06A90630B2E4
|
|
wd:statement/Q20948663-4F963A83-91D4-45C6-9731-986811BF3615
|
|
wd:statement/Q20948663-602F87B2-371D-4C8D-9197-EFF82911D2F5
|
|
wd:statement/Q20948663-7B73A800-CC82-4E08-B4E2-789E0F93839C
|
|
wd:statement/Q20948663-7D5DC5FD-C1A3-4204-9EA4-8C13CF4BF429
|
|
wd:statement/Q20948663-8AA55557-3490-49B0-9C7A-7948E678ABF9
|
|
wd:statement/Q20948663-A311DFDA-F4A5-4CCB-A693-0605EB2511CA
|
|
wd:statement/Q20948663-BF195117-4DD6-4DD6-8585-254DA240E3F0
|
|
wd:statement/Q20948663-D02869B8-E699-4DE3-8229-7472D4843B12
|
|
wd:statement/Q20948663-F5647466-F136-4D0B-A8AA-FB065670D536
|
|
wd:statement/Q20948663-FB1D8DB5-91A9-439C-B970-F3FF9C1295BC
|
|
p:P1579
|
wd:statement/Q20948663-6FE620BC-61BF-4ED3-8AB0-D78ABCA9D060
|
|
p:P2017
|
wd:statement/Q20948663-8555D10E-0B30-4486-877D-09DA0339F312
|
|
p:P2067
|
wd:statement/Q20948663-595230F8-FAF5-4041-837E-EAD231302754
|
|
p:P2115
|
wd:statement/Q20948663-D25C14C4-677A-4A79-964C-B1B23514FD6B
|
|
p:P2175
|
wd:statement/Q20948663-26BFDDF0-C8D1-4455-A69D-F13750E4F79B
|
|
wd:statement/Q20948663-8610AEB9-FA35-4F88-9169-585989B16B1A
|
|
p:P2275
|
wd:statement/Q20948663-2AA3BBB1-8AC9-47DA-A22B-BBCA787BD044
|
|
p:P231
|
wd:statement/Q20948663-863BAD6C-6935-48DB-BDC0-CA0327E9B041
|
|
p:P232
|
wd:statement/Q20948663-E19C2A5B-DB2D-4F31-8BDF-5852F93D340C
|
|
p:P233
|
wd:statement/Q20948663-3889E152-C854-4958-83B9-5D06D6FB2778
|
|
p:P234
|
wd:statement/Q20948663-B25CE486-DEB3-4360-A1A1-218A8718DCA4
|
|
p:P235
|
wd:statement/Q20948663-E8D6A860-4B7A-484A-A8CF-8D33F7878A35
|
|
p:P2566
|
wd:statement/Q20948663-DA3BB776-8292-4453-A090-76FB79987311
|
|
p:P267
|
wd:statement/Q20948663-BE733E5F-D878-4381-B761-DA0F27167AE2
|
|
p:P2671
|
wd:statement/Q20948663-528D4600-461F-4606-9E8F-FD4B54DE4D22
|
|
p:P274
|
wd:statement/Q20948663-5A616C66-6BF6-4ED2-84AE-221B2069F3F5
|
|
p:P279
|
wd:statement/Q20948663-D28AB92B-8023-4035-A9F4-EF7B592A687C
|
|
p:P2868
|
wd:statement/Q20948663-68D2372E-6443-4B26-805C-ABEF4E7F6EEC
|
|
wd:statement/Q20948663-B0463031-6DF9-45B9-8F29-BB4FFA22F17A
|
|
p:P2877
|
wd:statement/Q20948663-2D5CFA9D-5FCF-4966-8F74-120A80C6E30E
|
|
wd:statement/Q20948663-E77D24AD-5DCA-4F1B-92EA-82C54C1206C5
|
|
p:P2892
|
wd:statement/Q20948663-22A61195-BDCE-4DF7-852D-3A001B49F33B
|
|
wd:statement/Q20948663-AD2DA39D-1EB1-4AD4-8892-47F43DF71157
|
|
p:P31
|
wd:statement/Q20948663-D878C4BA-495B-49E1-A931-AAA16042527C
|
|
p:P3117
|
wd:statement/Q20948663-030BB9EA-7E1D-4E69-9683-E1D675ECB1E7
|
|
p:P3345
|
wd:statement/Q20948663-B1BF16C9-B4A0-4894-A61C-9389E5423C31
|
|
p:P3636
|
wd:statement/Q20948663-505FF70B-C107-4C67-B1BE-02174C90EABE
|
|
p:P366
|
wd:statement/Q20948663-9124F65C-DDAF-4096-83D5-FBD177D13F1E
|
|
p:P3780
|
wd:statement/Q20948663-26D8CC82-70C0-47D7-BADC-0B57A6FBDFD5
|
|
p:P4235
|
wd:statement/Q20948663-A855C8E0-1EE7-4ED2-B90A-07466A8F9D4E
|
|
p:P486
|
wd:statement/Q20948663-35BD13F7-EB2A-48D5-B88C-B356EF468C57
|
|
p:P592
|
wd:statement/Q20948663-BAAD9A05-0D6F-49A8-B83F-90B46E2F3746
|
|
p:P595
|
wd:statement/Q20948663-E217BDCC-13DE-4094-8020-96D1E68625C6
|
|
p:P6366
|
wd:statement/Q20948663-A35ADD04-24AB-482C-8C49-734B9E2CF53A
|
|
p:P638
|
wd:statement/Q20948663-9538F6D6-3EFC-4D0D-A47D-BC4CE409BAE9
|
|
p:P652
|
wd:statement/Q20948663-24FB38B9-919B-4F82-879C-7AA568EAFD4F
|
|
p:P661
|
wd:statement/Q20948663-42D75EED-7AB5-4ADC-9731-CB96616A115D
|
|
p:P662
|
wd:statement/Q20948663-F2B2FBDC-81B2-4FCF-9C8D-86F2B90EF86A
|
|
p:P665
|
wd:statement/Q20948663-AB58D1A7-450B-4464-9812-A1B12093A4C1
|
|
p:P683
|
wd:statement/Q20948663-A438FB8F-A10D-4581-9CC8-C42BDF1790EF
|
|
p:P715
|
wd:statement/Q20948663-1CC7E397-2ACC-467E-ABAF-122738862EEB
|
|
p:P7830
|
wd:statement/Q20948663-BCA1F20D-4CBA-4780-AE4F-11C0E8B6F72E
|
|
p:P8026
|
wd:statement/Q20948663-99E03CE1-9EB6-4E8D-BB9E-4A52D8B34655
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000192231>
|
|
p:direct-normalized/P2671
|
<http://g.co/kg/g/11b86wvrmf>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C548400>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2141296>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2781098529>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/5LF7>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/25027391>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25183872>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D10130>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_90942>
|
|
wdt:P10245
|
"a616008"
|
|
wdt:P10283
|
"C2781098529"
|
|
wdt:P11089
|
"23445617"
|
|
wdt:P11143
|
"Ixazomib"
|
|
wdt:P11198
|
"5067"
|
|
wdt:P11199
|
"PD003323"
|
|
wdt:P129
|
Proteasome 26S subunit, non-ATPase 14
|
|
Proteasome 20S subunit alpha 3
|
|
Proteasome 20S subunit alpha 6
|
|
Proteasome 20S subunit beta 10
|
|
Proteasome 20S subunit beta 2
|
|
Proteasome 20S subunit beta 8
|
|
Proteasome 20S subunit beta 5
|
|
Proteasome 20S subunit beta 6
|
|
Proteasome 20S subunit alpha 5
|
|
Proteasome 20S subunit alpha 8
|
|
Proteasome subunit beta 11
|
|
Proteasome 20S subunit alpha 2
|
|
Proteasome subunit beta 1
|
|
Proteasome 26S subunit, non-ATPase 1
|
|
Proteasome 20S subunit alpha 7
|
|
wdt:P1579
|
"18302358"
|
|
wdt:P2017
|
"B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O"
|
|
wdt:P2067
|
360.081^^xsd:decimal
|
|
wdt:P2115
|
"N0000192231"
|
|
wdt:P2175
|
multiple myeloma
|
|
amyloidosis
|
|
wdt:P2275
|
"ixazomib"@en
|
|
wdt:P231
|
"1072833-77-2"
|
|
wdt:P232
|
"810-246-8"
|
|
wdt:P233
|
"B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O"
|
|
wdt:P234
|
"InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1"
|
|
wdt:P235
|
"MXAYKZJJDUDWDS-LBPRGKRZSA-N"
|
|
wdt:P2566
|
"100.238.319"
|
|
wdt:P267
|
"L01XG03"
|
|
wdt:P2671
|
"/g/11b86wvrmf"
|
|
wdt:P274
|
"C₁₄H₁₉BCl₂N₂O₄"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
protease inhibitor
|
|
antineoplastic
|
|
wdt:P2877
|
"29353014"
|
|
"3742758"
|
|
wdt:P2892
|
"C2830202"
|
|
"C3273711"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID701025662"
|
|
wdt:P3345
|
"1723735"
|
|
wdt:P3636
|
"6V8"
|
|
wdt:P366
|
medication
|
|
wdt:P3780
|
Ninlaro
|
|
wdt:P4235
|
"ixazomib-mln9708"
|
|
wdt:P486
|
"C548400"
|
|
wdt:P592
|
"CHEMBL2141296"
|
|
wdt:P595
|
"8450"
|
|
wdt:P6366
|
"2781098529"
|
|
wdt:P638
|
"5LF7"
|
|
wdt:P652
|
"71050168A2"
|
|
wdt:P661
|
"25027391"
|
|
wdt:P662
|
"25183872"
|
|
wdt:P665
|
"D10130"
|
|
wdt:P683
|
"90942"
|
|
wdt:P715
|
"DB09570"
|
|
wdt:P7830
|
"Ixazomib"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E*
|